U

United Therapeutics Corporation

Biotech company develops PAH therapies

Computational Lab Co-op

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Internship · Spring 2026Silver Spring, MD, USANo salary listed

About the Job

Requirements

  • Candidates must be actively enrolled in a Master's or PhD program in a science or engineering discipline.
  • Candidates must be available to work 40 hours per week onsite in Silver Spring, Maryland.
  • Candidates need experience implementing modeling and simulation (PDE-based fluid dynamics, ODE-based signaling models, or agent-based modeling) or bioinformatics/machine learning skills, depending on the project.
  • Candidates must be proficient in at least one programming language such as R, Python, Julia, or Matlab.
  • Candidates should be self-motivated and able to work effectively in a team.
  • Candidates must have strong writing and communication skills.

Responsibilities

  • Conduct research on mathematical modeling approaches to add features to the in-silico lung model, evaluating their suitability for research questions and feasibility of implementation.
  • Identify data in literature and public repositories suitable for training and validating mathematical models.
  • Implement mathematical models by developing well-documented code using version control systems.
  • Present plans and results regularly to members of the computational lab and other company scientists.
  • Potential projects include simulating interactions between lung tissue mechanics and fluid dynamics, focusing on how disease-related mechanical changes affect clinical measurements related to hemodynamics and pulmonary function testing.
  • Potential projects include applying statistical or machine learning approaches to large-scale molecular data, such as transcriptomics and proteomics, to derive insights into lung function and drug response.
  • Potential projects include generating mechanistic ODE-based models of signaling pathways relevant to lung physiology and drug response, and applying quantitative systems pharmacology approaches to clinical development objectives.
  • Potential projects include applying agent-based modeling to represent the behavior of cell populations on tissue-engineered scaffolds.

About the Company

United Therapeutics Corporation

Biotech company develops PAH therapies

United Therapeutics develops medicines for pulmonary arterial hypertension and other rare diseases, and pursues organ manufacturing through its Xenotransplantation efforts. Its drugs are given as oral tablets, intravenous infusions, or inhaled therapies to open damaged lung vessels and support heart function, while its organ programs aim to create bioengineered organs from donor animals to reduce rejection. The company differentiates itself by pairing a pharmaceutical portfolio with regenerative medicine and organ manufacturing, and by operating as a public-benefit corporation with sustainable facilities. Its goal is to end the organ transplant shortage by supplying transplantable organs while improving patient outcomes through better drug delivery and regenerative medicine.

Company size
Not listed
Company stage
IPO
Headquarters
Silver Spring, MD
Founded
1996

Recently Posted Jobs

Explore more opportunities at United Therapeutics Corporation

See more jobs